AKAM vs XGN · P/E 27, rev $2.17B vs rev $37.2M
Akamai Technologies Inc (AKAM) versus Exagen Inc (XGN) — a side-by-side from cached financials, not a winner call.
Akamai Technologies Inc (AKAM) is a software - infrastructure company listed on US.
Exagen Inc (XGN) is a diagnostics & research company listed on US.
Latest reported AKAM revenue for 2026-06-30 was $2.17B. Net income was $185.7M. AKAM currently screens at market cap $11.31B and trailing P/E 26.7.
Latest reported XGN revenue for 2026-06-30 was $37.2M. Net income was -$7.2M. XGN currently screens at market cap $154.1M.
AKAM currently screens at market cap $11.31B and trailing P/E 26.7. XGN currently screens at market cap $154.1M.
Not investment advice. Open the AKAM and XGN stock pages for the full models.
Not investment advice.